BETTY CHUKWUMA: Open Payments
NPI 1285093062 · SEBASTIAN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 20 payments from 12 companies in 2025. Trend: 2023 $2,249 · 2024 $2,331 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $218 |
| E.R. Squibb & Sons, L.L.C. | 3 | $80 |
| Neurocrine BioSciences, Inc. | 2 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $53 |
| Novo Nordisk Inc | 1 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $48 |
| ABBVIE INC. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 1 | $44 |
| Almatica Pharma LLC | 1 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: INVEGA SUSTENNA, COBENFY, INGREZZA, Wegovy, VRAYLAR, LOREEV XR, AUSTEDO XR, ABILIFY MAINTENA.
Industry payments across FL — which companies pay providers there.
